Concepedia

Katherine H. Walsh

KH

5

Publications

730

Citations

5

H-Index

2013

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Broad Institute

Brigham and Women's Hospital

University of North Carolina at Chapel Hill

Katherine H. Walsh is an author at Harvard University specializing in combination therapy, tumor biology, and cell signaling.

Top concepts

Publications per year

2013–2021

5

Publications

5

Genetic heterogeneity of diffuse large B-cell lymphoma

Jenny Zhang, Vladimir Grubor, Cassandra Love et al. · Proceedings of the National Academy of Sciences · 2013 · 530 citations · Full text

Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers

Rita Sulahian, Jason J. Kwon, Katherine H. Walsh et al. · Cell Reports · 2019 · 90 citations · Full text

, , +17

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors

Thomas P. Howard, Taylor E. Arnoff, Melinda R. Song et al. · Cancer Research · 2019 · 69 citations · Full text

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

Andrew M. Waters, Tala O. Khatib, Bjoern Papke et al. · Cell Reports · 2021 · 31 citations · Full text

Abstract 4550: Increased IL-27 is associated with poor prognosis in renal cell carcinoma and supports use of SRF388, a first-in-class IL-27p28 blocking antibody, to counteract IL-27-mediated immunosuppression in this setting

Matthew Rausch, Jing Hua, Devapregasan Moodley et al. · Cancer Research · 2020 · 10 citations

Rows per page

1–5 of 5